Singapore, May 16, 2008: Australia’s Murdoch University has signed a MoU with Malaysian clinical research organization Info Kinetics to deliver accredited drug analysis services to Western Australian organizations.

 

A prepared release by Info Kinetics said Murdoch University's collaboration with it would leverage on each other's strengths with the intent being to develop a commercial operation that will support drug development companies, biotech companies. This initiative will support the State Government's push to secure the future of clinical trials in WA.

 

Murdoch University's Dean of Pharmacy, Associate Professor Robert Coltrona said the partnership would start with analysis work but could grow to deliver a broader suite of clinical services.

 

"Info Kinetics operate out of the Malaysian University of Science in Penang and have the experience to assist Murdoch in developing quality systems that will allow us to compete in a highly regulated international market," Prof. Coltrona said.

 

"This will be the first time that a Western Australian operation has achieved the necessary accreditation to produce clinical data that is widely accepted and will possibly lead to the development of new and exciting drug therapies."

 

The establishment of this partnership will see drug development and biotech companies benefit from reduced costs and a quicker turn around on results for local players.

 

"By signing this MoU with Murdoch, Info Kinetics now has access to our state-of-the-art Separation Science Laboratory which boasts some of the most advanced analytical research equipment in Australia," Professor Coltrona said.

 

"With the establishment of the new Fiona Stanley Hospital campus at Murdoch, this will open up future opportunities for Murdoch University to provide the hospital with clinical services."